Canning
Since 1965 we have helped people like you to communicate more effectively while doing business across borders. The worldwide web is full of companies offering to do these things for you. What makes us different? Explore our website and have a look. Or, even better, contact us and talk to one of our team about what we could do for you and your organisation. Our existing clients know we are the best. You need to discover that for yourself.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
What the Most Favored Nation (MFN) policy means for UK Pharma
White Papers and Resources | October 20, 2026 | Amiculum
By Jed Avissar and Manca Povsic
ANTHEM strengthens team with three appointments following Healthy Influence launch
Press Releases | October 19, 2026 | Resonant Group
Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth
Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy
Press Releases | October 14, 2026 | Genesis Research Group
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...
Your AI pilot works. That’s the problem.
White Papers and Resources | October 14, 2026 | 11 London
What breaks when you scale it won't be the model. It'll be your data.
“We’ve been told we can’t touch AI”
White Papers and Resources | October 14, 2026 | 11 London
It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...
What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness
Press Releases | October 12, 2026 | Medscape Education
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...
On GLOBE Final Rule
Press Releases | October 9, 2026 | Genesis Research Group
The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....
Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation
Press Releases | October 8, 2026 | Medscape Education
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
Pharma leadership strategies for talent, AI adoption, and continuous learning
White Papers and Resources | October 8, 2026 | Inizio
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous...
Invited, but not equipped: patient involvement needs more than an open door
White Papers and Resources | October 8, 2026 | Cuttsy + Cuttsy
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.